J_2000 schreef op 23 januari 2017 22:33:
[...]
Semper Nescio.. graag even excuses.. ik volg het al lang!! ;-)
With the launch of licensee Exact Sciences' FDA-approval Cologuard test, MDxHealth expects to recognize a milestone fee and deferred license fees in excess of $0.5 million in the near term. In addition, pursuant to its license agreement with Exact Sciences, MDxHealth is eligible to receive minimum annual maintenance fees of $100,000 per year, sales milestones of $300,000 after Cologuard attains net sales of $10 million, $750,000 after Cologuard attains net sales of $50 million, and $1 million after Cologuard attains net sales of $50 million in a single calendar year, as well as running royalties in the mid-single digit range. The license agreement is expected to remain in effect until the last of the licensed patents expires in 2028.
Die 50 million heeft Exact Sciences gehaald in Q3!.. Uit vorige mijlpaalbetalingen hebben we gezien dat MDxHealth ze inboekte in zelfde kwartaal..
mdxhealth.com/press-release/mdxhealth...